共查询到19条相似文献,搜索用时 218 毫秒
1.
2.
欧盟兽用抗菌药耐药性管理概述 总被引:1,自引:0,他引:1
介绍负责管理欧盟兽用抗菌药耐药性的欧洲药品局下设的兽用药品委员会、健康与消费者保护司和食品安全局等相关管理机构以及成立耐药性管理工作组、进行耐药性风险分析、制定相关文件和实施耐药性监测等的管理措施,为我国兽药耐药性相关政策的制定和措施的实行提供参考. 相似文献
3.
介绍日本兽用抗菌药耐药性监控系统并分析日本食品动物源细菌耐药现状和抗菌药使用情况,以期为我国动物源细菌耐药性监控管理提供参考和借鉴。 相似文献
4.
5.
6.
7.
8.
9.
10.
11.
介绍了2011年国际食品法典委员会(CAC)制定的《食源性抗菌药耐药性风险分析指南》主要内容,为非人用抗菌药相关的食源性抗菌药耐药性应用及我国制定抗菌新兽药的安全评价原则、风险评估方案和管理政策提供参考. 相似文献
12.
13.
J. F. Prescott 《Equine Veterinary Education》2021,33(10):539-545
Antimicrobial stewardship (AMS) is the term increasingly used to describe the multiple approaches needed to sustain the efficacy of antimicrobial drugs in the face of the increasing development and spread of antimicrobial resistance in bacterial pathogens, and the global crisis in medicine that it is engendering. The concept and the practices associated with AMS continue to evolve but the general approach is a dynamic and multifaceted one of continuous improvement based on reducing, improving, monitoring and evaluating the use of antimicrobials so as to preserve their future efficacy and to protect human and animal health. Using many equine examples, this basic overview discusses the multiple and interacting elements of AMS: Practice guidelines, infection control and prevention, clinical microbiology, resistance and use surveillance, dosage, pharmacokinetics and pharmacodynamics, regulation, education and owner compliance, leadership, coordination and measurement. There have been impressive advances in recent years in reporting and analysis of AMR in horses, in the scrutiny and assessment of how antimicrobial drugs are used in horses and in identification of areas for improvement including dosing, surgical prophylaxis, infection control, development of practice standards and the use of clinical microbiology. Antimicrobial stewardship is taking shape as we start to see the emergence of evidence-based recommendations but far more is required. Containing and even rolling back AMR will need the continued engagement of practitioners, equine national and international practitioner organisations, researchers and educators in the academic community, horse owners, regulators and others. 相似文献
14.
15.
D A Dargatz J L Traub-Dargatz N C Sangster 《Veterinary Clinics of North America: Equine Practice》2000,16(3):515-36, ix-x
Antimicrobial and anthelmintic resistance are growing issues for the equine practitioner. The development of antimicrobial or anthelmintic resistance is a source of significant concern because of increased frequency of treatment failures and increased treatment costs. In addition, antimicrobial resistance may have important consequences for public health. Only through judicious use can the efficacy of antimicrobials and anthelmintics be prolonged. This article discusses the development of resistance and suggestions for control. 相似文献
16.
Barrett DC 《The Veterinary record》2000,146(19):545-550
Respiratory disease in growing cattle has both animal welfare and economic implications, but the use of antimicrobial drugs to treat and control it is under public scrutiny owing to concerns that their use in food-producing animals may be detrimental to human health. This paper outlines criteria for the selection of appropriate and cost-effective drugs, based on good dinical practice and sound economic principles. It also suggests that these principles should be integrated into quality assurance schemes, and that the monitoring of antimicrobial resistance patterns among known bacterial respiratory pathogens should be improved. 相似文献
17.
Agnes Agunos Dave Léger Carolee Carson 《The Canadian veterinary journal. La revue veterinaire canadienne》2012,53(12):1289-1300
This paper reviews common therapeutic applications of antimicrobials in broiler chicken production in relation to Canadian guidelines, surveillance data, and emerging public health concerns about antimicrobial use (AMU). Escherichia coli, Clostridium perfringens, and Staphylococcus spp., were reviewed because of their animal health and economic significance. Enterococcus cecorum and Salmonella were included because of their importance in antimicrobial resistance (AMR) surveillance. This review identified that i) antimicrobials are available in Canada to treat infections by these agents, but may be through over the counter or extra-label use, ii) prevalence rates for these diseases are unknown, iii) antimicrobial use estimates in broilers are lacking, and iv) AMR has emerged in clinical isolates, though data are very sparse. This review highlights the need for surveillance of AMU and AMR in broiler chickens in Canada. 相似文献
18.
D Jordan 《Australian veterinary journal》2019,97(8):283-284
Debate about antimicrobial resistance (AMR) in animals and the impact on humans is often inappropriately focussed on the crude amount of antimicrobials used in animals without deference to issues of ‘intensity of use’, ‘quality of use’ and especially the class of agents being administered. In the latter case, tools for helping to manage how the use of specific antimicrobial agents impact on the risk and consequences of antimicrobial resistance in humans have been available for almost two decades. These consist of antimicrobial ratings systems, which formally define the importance of each individual agent in human health by assigning them to a position on a graduated scale of ‘importance’ comprising up to four categories of risk. Until recently, these published ratings have only had a modest impact on antimicrobial stewardship at the frontline of medical and veterinary practice, although they will undoubtedly have a substantial influence into the future. This article considers the evolution of the available ‘antimicrobial ratings systems’ applicable to Australian and international settings and their pivotal future‐role in the educating of animal managers, policy makers and prescribers. Faithful application of these rating systems at all levels of decision making to do with antimicrobial use is now seen as central to the protection of animals, humans and economies from the scourge of AMR. 相似文献
19.
The management of risk arising from the use of antimicrobial agents in veterinary medicine in EU/EEA countries – a review 下载免费PDF全文
K. Törneke J. Torren‐Edo K. Grave D. K. J. Mackay 《Journal of veterinary pharmacology and therapeutics》2015,38(6):519-528
Antimicrobials are essential medicines for the treatment of many microbial infections in humans and animals. Only a small number of antimicrobial agents with new mechanisms of action have been authorized in recent years for use in either humans or animals. Antimicrobial resistance (AMR) arising from the use of antimicrobial agents in veterinary medicine is a concern for public health due to the detection of increasing levels of resistance in foodborne zoonotic bacteria, particularly gram‐negative bacteria, and due to the detection of determinants of resistance such as Extended‐spectrum beta‐lactamases (ESBL) in bacteria from animals and in foodstuffs of animal origin. The importance and the extent of the emergence and spread of AMR from animals to humans has yet to be quantified. Likewise, the relative contribution that the use of antimicrobial agents in animals makes to the overall risk to human from AMR is currently a subject of debate that can only be resolved through further research. Nevertheless, risk managers have agreed that the impact on public health of the use of antimicrobials in animals should be minimized as far as possible and a variety of measures have been introduced by different authorities in the EU to achieve this objective. This article reviews a range of measures that have been implemented within European countries to reduce the occurrence and the risk of transmission of AMR to humans following the use of antimicrobial agents in animals and briefly describes some of the alternatives to the use of antimicrobial agents that are being developed. 相似文献